AI - Deep Genomics
Revolutionizing genetic medicine through advanced AI technology and RNA-focused therapeutics discovery, unlocking solutions for any gene and genetic condition.
- Name
- Deep Genomics -https://www.deepgenomics.com/
- Last Audited At
About Deep Genomics
Deep Genomics is a world-class genetic medicine company that leverages advanced AI technology to unlock the potential of RNA-focused therapeutics. Established to tackle the intricacies of RNA biology data and discover novel targets, Deep Genomics aims to develop therapies for any gene and any genetic condition.
In 2018, their proprietary AI Platform marked a breakthrough in identifying targets where RNA splicing was the defect. Fast forward to 2023, and they introduced BigRNA, the most advanced AI Foundation Model for RNA disease mechanisms and candidate therapies. Currently, they're working on expanding this platform with BigRNA+, allowing them to pursue more complex genetic diseases and new discoveries in RNA biology.
Deep Genomics' AI-powered approach enables unprecedented numbers of valuable medicines by combining prediction and scale. Their mission is driven by the belief that everyone will face a genetic condition in their lifetime. With the advent of RNA therapies, they envision addressing most genetic conditions through precisely targeted treatments. As genetic targets become less understood in complex diseases, the AI Platform plays an increasingly important role in identifying novel targets and therapies.
Deep Genomics continues to innovate at the intersection of AI, RNA biology, and automation, revolutionizing drug development for a global audience.
